HF
KYNB

HRT Financial’s Kyntra Bio KYNB Stock Holding History

HRT Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-963
Closed -$12K – 2772
2024
Q4 		$12K Buy
+963
New +$8.95K ﹤0.01% 2259
2024
Q3 		– Sell
-7,165
Closed -$159K – 2651
2024
Q2 		$159K Buy
+7,165
New +$221K ﹤0.01% 1702
2024
Q1 		– Sell
-14,231
Closed -$315K – 2550
2023
Q4 		$315K Buy
14,231
+11,008
+342% +$166K ﹤0.01% 1603
2023
Q3 		$69K Buy
+3,223
New +$127K ﹤0.01% 1981
2023
Q2 		– Sell
-7,724
Closed -$3.6M – 2711
2023
Q1 		$3.6M Buy
+7,724
New +$4.09M 0.04% 355
2022
Q3 		– Sell
-2,414
Closed -$637K – 3018
2022
Q2 		$637K Buy
2,414
+646
+37% +$165K 0.01% 1316
2022
Q1 		$531K Sell
1,768
-1,660
-48% -$579K ﹤0.01% 1592
2021
Q4 		$1.21M Buy
+3,428
New +$1.07M 0.01% 963
2019
Q4 		– Sell
-501
Closed -$463K – 1308
2019
Q3 		$463K Buy
+501
New +$550K 0.02% 717

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's KYNB Position: Q1 2025 in Review

HRT Financial sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 963 shares — an estimated $12K sold.

HRT Financial first reported a position in KYNB in Q3 2019 and held it in 9 quarters. The position peaked at $3.6M in Q1 2023. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • HRT Financial reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 963 Kyntra Bio shares in Q1 2025, an estimated $12K.
  • HRT Financial first reported a position in Kyntra Bio in Q3 2019 and held it in 9 quarters.
  • HRT Financial's Kyntra Bio position peaked at $3.6M in Q1 2023.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.